Key points from article :
Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment.
US clinical trial involved 108 patients with large B cell lymphoma.
CAR T cell therapy boosts the immune system’s ability to recognise and destroy cancer cells.
Studies are also underway in the UK to test the treatment.
CAR T was also shown to have long-term benefits with non Hodgkin lymphoma patients.
The study was published in the New England Journal of Medicine.
